10th international conference neonatal childhood
play

? 10th International Conference Neonatal & Childhood Pulmonary - PowerPoint PPT Presentation

3/10/2017 Clinical problem Surgical Interventions for Pulmonary Vein Stenosis Christopher Caldarone Hospital for Sick Children, Toronto ? 10th International Conference Neonatal & Childhood Pulmonary Vascular Disease March 10, 2016 San


  1. 3/10/2017 Clinical problem Surgical Interventions for Pulmonary Vein Stenosis Christopher Caldarone Hospital for Sick Children, Toronto ? 10th International Conference Neonatal & Childhood Pulmonary Vascular Disease March 10, 2016 San Francisco TAPV repair: Surgical repair of TAPV Strong era effect – We are getting better! ? Karamlou, Circulation 2007 1

  2. 3/10/2017 TAPV repair: TAPV repair: Still a problem in ‘unfavorable patients’ Early hazard phase for reoperation Karamlou, Circulation 2007 Karamlou, Circulation 2007 TAPV repair: Residual stenosis predicts reop Risk Factors for Reoperation % Freedom From Reoperation Unobstructed High risk population Small PV confluence Mixed type Small patients (<2 kg) Right atrial isomerism Postop obstruction Years From Complete Repair Yun, JTCVS 2005 Karamlou, Circulation 2007 2

  3. 3/10/2017 Diagnosis: Post-repair Pulmonary Vein Stenosis Post-repair pulmonary vein stenosis Three varieties • Anastomotic stenosis • Fibrosis of confluence • Retrograde ‘UPSTREAM’ progression into lungs – Unilateral or bilateral ? – Often relentless Surgical evaluation: Who is operable? Post-repair pulmonary vein stenosis ? 3

  4. 3/10/2017 Extent of disease can predict survival: PVS Score PVS Score • Grading of PVS in each pulmonary vein 0: None 1: Mild-Moderate 2: Severe 3: Occlusion P<0.0001 • Summation of PVS grades of 4 PVs • Possible range: 0 - 12 Yun, JTCVS 2005 Yun, JTCVS 2005 ‘Upstream’ pulmonary veins ‘Upstream’ pulmonary veins (Not here) Operate HERE! Use a clinical surveillance protocol to detect recurrence early! 1, 6, 12 months (at least) LoRito, JTCVS 2016 LoRito, JTCVS 2016 4

  5. 3/10/2017 Congenital PVS Congenital PVS ? Viola, JTCVS 2011 Surgical treatment for PR-PVS: PR-PVS and congenital PVS Sutureless repairs ? 5 year survival ~55% Quinonez, JTCVS, 2015 5

  6. 3/10/2017 John Coles’ Hypothesis John Coles’ Hypothesis Irregular contour >> geometric distortion which is • ‘Sutureless repair’ ‘fixed’ by a sutureline • Atrium to pericardium – No direct anastomotic suture Distortion – “Controlled bleed” into neoatrium Upstream • No geometric constraints on tissue propagation >>> Tissue conforms to local flow patterns Flow Local disturbance injury Sutureless Repairs: A Controlled Bleed Courtesy: Nicola Viola 6

  7. 3/10/2017 Post-repair PVS Post-repair PVS Yun, JTCVS 2005 Devaney, Ann Thor Surg 2006 Mixed TAPVD If beneficial for PR-PVS, should we use sutureless repairs for all TAPV patients? > Prophylactic procedure Simplifies complex geometry Honjo, Ann Thor Surg 2010 7

  8. 3/10/2017 Primary sutureless repair for TAPV Primary sutureless repair for TAPV Konstantinov 2004 Konstantinov 2004 Primary sutureless repair for TAPV Primary sutureless repair for TAPV Positive Attributes: Negative Attributes: Less precision required Broncho-atrial fistula? >> EASY Pleural disruption? Short learning curve Easier to teach Embolism? No circulatory arrest >>> Uncommon Konstantinov 2004 Konstantinov 2004 8

  9. 3/10/2017 Primary sutureless repair for TAPV Primary sutureless repair for TAPV Can we prove there is a benefit? • Shi et al • n=768 Sample size requirement • Lower restenosis in patients with preop PVS – Assume 50% decrease PR-PVS – 150 patients (10 years of accrual) needed � High risk populations >> smaller sample size � Registry (e.g. PVS Network) will enable � Low risk of adverse events makes it attractive Yun, JTCVS 2005 Shi, Circulation 2017 Surgical treatment for PR-PVS: Conclusions: Sutureless repairs Lung transplant • Sutureless repairs for treatment of post-repair pulmonary vein stenosis >> ‘superior’ midterm results • Sutureless repairs for prevention of PVS – Less clearly supported, but little downside ? – Recommended for: • patients at high risk of recurrence • mixed TAPV 9

  10. 3/10/2017 Lung transplant and PVS Lung transplant and PVS 5 year survival: 60% BO-free survival ~50% Preop ECMO is risk factor* • 12 congenital PVS + 8 acquired PVS • Median wait: 26d • Bilateral lung transplants on CPB J HeartLungTransplant2013;32:621–625 J HeartLungTransplant2013;32:621–625 Dual lumen ECMO catheter Waiting for transplant RA > LA • Mechanical Pulmonary Support – ECMO • Rapidly evolving techniques – RA>LA (pump + oxygenator, special cannula) – PA>LA (oxygenator) Javidfar JTCVS 2012 10

  11. 3/10/2017 Paracorporeal lung assist device (PLAD) Paracorporeal lung assist device (PLAD) PA > LA PA > LA • Stabilize awaiting transplant • Enable therapies in non-hypertensive lungs • Enable surgical interventions Sweet, JTCVS 2014, Gazit Pediat Transplant 2016 Conclusion • Surgery is not enough • Immediately achievable: – Match surveillance to velocity of disease • Detect while still treatable • Use Clinical Surveillance Protocol (1,6,12 months) • Use dedicated ‘PVS Team’ to manage surveillance and treatment • Our future – Combination therapy offers opportunities • Integrate catheter-based <> surgical interventions • Mechanical pulmonary support <> transplant <> MPS-enabled therapies • Medical adjuncts (losartan, gleevec, avastin) 11

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend